High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition

Anngela C. Adams(University of Arizona), Karen Taraszka Hastings(University of Arizona), David J. DiCaudo(Mayo Clinic in Arizona), Kenneth H. Buetow(Arizona State University), Denise J. Roe(University of Arizona), Mark Gimbel(The University of Texas MD Anderson Cancer Center), Haiyan Cui(Tongji University), Elizabeth S. Borden(University of Arizona), Anne M. Macy(University of Arizona), Jade Homsi(The University of Texas MD Anderson Cancer Center), Nick Thomson(The University of Texas MD Anderson Cancer Center), Melissa A. Wilson(National Human Genome Research Institute)
Cancers
April 28, 2022
Cited by 8


Related Papers